ISSUER ANNOUNCEMENT · EIN PRESSWIRE
Lilly Israel taps XOLTAR to launch a personalized digital patient support program for Type 2 Diabetes and Obesity
Supplied by the issuer through EIN Presswire. This announcement is separate from Factavelle’s reporting; its claims have not been independently verified. Feed wording is preserved, with formatting adapted for readability.
Three-year collaboration aims to strengthen therapeutic alliance, encourage healthy behaviors and improve long-term engagement.
NEW YORK, NY, UNITED STATES, October 12, 2026 /EINPresswire.com/ -- Eli Lilly Israel has signed a three-year …